Lipocine Inc. — Investor Relations & Filings
Lipocine Inc. is a clinical-stage biopharmaceutical company that develops treatments for metabolic, endocrine, and central nervous system disorders. The company leverages its proprietary Lip'ral drug delivery technology to enhance the oral absorption of water-insoluble drugs, aiming to improve patient compliance and therapeutic outcomes. Its portfolio includes TLANDO®, an FDA-approved oral testosterone replacement therapy. Lipocine's development pipeline features candidates for conditions such as non-alcoholic steatohepatitis (NASH), postpartum depression, obesity, and prevention of preterm birth. The company's strategy often involves using the 505(b)(2) regulatory pathway to develop improved formulations of established drugs.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Proxy Solicitation & Information Statement 2023 | 2023-03-27 | English | |
| Director's Dealing 2023 | 2023-03-24 | English | |
| Director's Dealing 2023 | 2023-03-20 | English | |
| Annual Report 2023 | 2023-03-20 | English | |
| Director's Dealing 2023 | 2023-03-17 | English | |
| Regulatory Filings 2023 | 2023-03-17 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2023
15 filings
| |||||
| 12525704 | Proxy Solicitation & Information Statement 2023 | 2023-03-27 | English | ||
| 12525705 | Director's Dealing 2023 | 2023-03-24 | English | ||
| 12525708 | Director's Dealing 2023 | 2023-03-20 | English | ||
| 12525712 | Annual Report 2023 | 2023-03-20 | English | ||
| 12525714 | Director's Dealing 2023 | 2023-03-17 | English | ||
| 12525716 | Regulatory Filings 2023 | 2023-03-17 | English | ||
| 12525717 | Regulatory Filings 2023 | 2023-03-13 | English | ||
| 12525724 | Annual Report 2022 | 2023-03-10 | English | ||
| 12525725 | Regulatory Filings 2023 | 2023-03-10 | English | ||
| 12525730 | Regulatory Filings 2023 | 2023-03-10 | English | ||
| 12525731 | Regulatory Filings 2023 | 2023-03-10 | English | ||
| 12525732 | Regulatory Filings 2023 | 2023-01-11 | English | ||
| 12525743 | Regulatory Filings 2023 | 2023-01-05 | English | ||
| 12525745 | Regulatory Filings 2023 | 2023-01-05 | English | ||
| 12525746 | Director's Dealing 2023 | 2023-01-04 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Lipocine Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35074/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35074 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35074 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35074 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35074}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Lipocine Inc. (id: 35074)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.